Back to results
US 11,884,930 B2Granted
Method of inactivating a glucocorticoid receptor gene in an isolated cell
AssigneesSangamo BioSciences, Inc., City of Hope
InventorsAndreas Reik, Michael Jensen, Michael C. Holmes, Philip D. Gregory, Dale Ando
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods and compositions for inactivation of the human glucocorticoid receptor (GR) gene by targeted cleavage of genomic DNA encoding the GR. Such methods and compositions are useful, for example, in therapeutic applications which require retention of immune function during glucocorticoid treatment.
Claims12
A method of selecting isolated human cells comprising a transgene integrated into an endogenous glucocorticoid receptor (GR) gene, the method comprising:
- a) introducing:
- i) one or more polynucleotides encoding a first and second pair of zinc finger nuclease (ZFN);
- and
- ii) a polynucleotide comprising a transgene flanked by homology arms that target a human glucocorticoid receptor (GR) gene into isolated human cells such that the transgene is integrated into an endogenous GR gene,
- wherein
- the first ZFN comprises:
- a zinc finger DNA-binding domain comprising the following recognition helices in the following order:
- (SEQ ID NO:
- 23)
- TSRALTA;
- (SEQ ID NO:
- 17)
- DRANLSR;
- (SEQ ID NO:
- 24)
- RSDNLSE;
- and
- (SEQ ID NO:
- 26)
- ERANRNS;
- and
- the second ZFN comprises:
- a zinc finger DNA-binding domain comprising the following recognition helices in the following order:
- (SEQ ID NO:
- 33)
- DSWNLQV;
- (SEQ ID NO:
- 27)
- RSANLTR;
- (SEQ ID NO:
- 30)
- TSGNLTR;
- and
- (SEQ ID NO:
- 31)
- TSGSLTR;
- or
- the first ZFN comprises:
- a zinc finger DNA-binding domain comprising the following recognition helices in the following order:
- (SEQ ID NO:
- 42)
- RSANLAR;
- (SEQ ID NO:
- 43)
- RSDNLRE;
- (SEQ ID NO:
- 44)
- QSSNLAR;
- and
- (SEQ ID NO:
- 45)
- QSADRTK;
- and
- the second ZFN comprises:
- a zinc finger DNA-binding domain comprising the following recognition helices in the following order:
- (SEQ ID NO:
- 40)
- RQDCLSL;
- (SEQ ID NO:
- 37)
- RNDNRKT;
- (SEQ ID NO:
- 38)
- RSDNLSR;
- and
- (SEQ ID NO:
- 39)
- TNQNRIT;
- and
- b) contacting the isolated human cells obtained in step a) with a corticosteroid such that cells not comprising the integrated transgene are killed and cells comprising the transgene integrated into the endogenous GR gene are selected.
67 more elements
Dependencies are inferred from the claim text.